1. DAHANCA 33: functional image-guided dose-escalated radiotherapy to patients with hypoxic squamous cell carcinoma of the head and neck (NCT02976051). (1st February 2020) Authors: Saksø, M.; Primdahl, H.; Johansen, J.; Nowicka-Matus, K.; Overgaard, J. Journal: Acta oncologica Issue: Volume 59:Number 2(2020) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0268: FAZA PET hypoxia as a marker of loco-regional recurrence in HNSCC? Results from the DAHANCA 24 trial. (April 2018) Authors: Saksø, M.; Mortensen, L.; Primdahl, H.; Johansen, J.; Kallehauge, J.; Hansen, C.; Overgaard, J. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0388 A prospective multicenter DAHANCA study of hyperfractionated accelerated RT for head and neck cancer. (April 2019) Authors: Saksø, M.; Andersen, E.; Bentzen, J.; Andersen, M.; Johansen, J.; Overgaard, J.; Eriksen, J.G. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗